SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,407.01 |
| Enterprise Value ($M) | 1,246.60 |
| Book Value ($M) | 449.43 |
| Book Value / Share | 7.06 |
| Price / Book | 3.13 |
| NCAV ($M) | 236.53 |
| NCAV / Share | 3.71 |
| Price / NCAV | 5.95 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.31 |
| Return on Assets (ROA) | -0.22 |
| Return on Equity (ROE) | -0.32 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.11 |
| Current Ratio | 4.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 456.40 |
| Assets | 669.30 |
| Liabilities | 219.87 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Rubric Capital Management LP | 5.79 | ||
| 13G/A | Vanguard Group Inc | 10.78 | 1.60 | |
| 13G/A | BlackRock Inc. | 13.90 | 3.85 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 307,877 | 1,259,440 | 24.45 | |
| 267,547 | 1,184,375 | 22.59 | |
| 569,119 | 2,633,041 | 21.61 | |
| 163,867 | 1,108,090 | 14.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RXRX – Recursion Pharmaceuticals, Inc. | SANA – Sana Biotechnology, Inc. |
| SCPH – scPharmaceuticals Inc. | SLDB – Solid Biosciences Inc. |
| SLRN – Acelyrin, Inc. |
Financial data and stock pages provided by
Fintel.io